Judge Announces Trial Dates for Consolidated NuvaRing DVT Trials

Tampa, FL (Law Firm Newswire) September 27, 2012 – Women who suffered from DVT, blood clots or pulmonary embolism after using the NuvaRing contraceptive device have filed lawsuits against the manufacturer, and a federal judge has announced a trial date for the consolidated cases.

“DVT and pulmonary embolism are quite serious conditions,” said Greg Grambor, an expert on DVT and president of VascularPRN, a distributor of DVT prevention devices. “An important preventative measure is the use of compression therapy, usually when a patient is confined to bed for three days or more.”

Deep Vein Thrombosis, or DVT, is blood clot that occurs in a deep vein, predominantly in the leg. It is characterized by swelling, pain, warmness and redness. Pulmonary embolism is often a result of DVT and occurs when a blood clot comes off and travels to the lung, blocking the main artery or one of its branches. In patients requiring long hospital stays, venous compression devices can prevent the conditions by applying pressure to the legs, thereby increasing blood flow.

NuvaRing is a vaginal ring contraceptive that is used once a month, and releases hormones into the bloodstream. The device is produced by Merck and Organon Pharmaceuticals, and was marketed as having less hormones than other contraceptives.

According to the FDA, the agency has received more than 1,000 reports of injury or death resulting from a blood clot injury in women who used NuvaRing. The FDA released a report last year that said that that type of contraceptive may heighten the risk of blood clots perhaps as much as 56 percent of the time. According to a study from the British Medical Journal, the increased risk may be as much as 90 percent.

A federal judge will hear the consolidated cases in a Missouri Multi-District Litigation court. More than 1,000 patients have filed suits. Judge Rodney W. Sippel said that a trial date in May 2013 has been set for the first of the trials.

To learn more about frequently asked questions regarding DVT, and view the PolyGel portable device, Sequential Compression Devices, or IPC devices, visit http://www.vascularprn.com/or call 800.886.4331. Vascular PRN has decades of experience helping nursing homes, surgery centers and hospitals, managed care organizations, and other institutions with their DVT product needs.

To learn more about a Sequential Compression Device, SCD boots, or the Skin IQ™ coverlet, visit www.vascularprn.com or call 800-886-4331.

Vascular PRN
601 S. Falkenburg Road, Suite 1-4
Tampa, FL 33619
Phone: 800.886.4331

• ADVANTAGE - Long Term and Post Acute Care
  Addressing the Sexual Needs of Seniors by Brian Garavaglia Older adults have sexual needs, which have often been minimized by the rest of the population. Furthermore, older adults that live in nursing home environments also have sexual needs that often are left unaddressed. Although addressing the topic has often been a sticky subject, a British [...]
• ADVANTAGE - Long Term and Post Acute Care
  Case Study – “Suit: Facility let woman ‘waste away” by Steve Moran Suit: Facility let woman ‘waste away’ is the title of a front page article in the Sacramento Bee, my local paper. Here is a brief summary of the lawsuit: Joan Boice was suffering from Alzheimer’s and was no longer able to live at [...]
• ADVANTAGE - Long Term and Post Acute Care
  Building a Better SNF Health systems are re-examining their post-acute care strategies and SNF partnerships. By Julie Schulz, MD After steadily migrating out of the skilled nursing facility (SNF) market over the past decade,health systems are re-examining their post-acute care (PAC) strategies and the potential value of SNF partnerships. This renewed consideration is directly tied [...]

See other news sources publishing this article. BETA | Tags: Compression booties, Leg pump, Lymphedema boots, Lymphedema pump, SCD, SCD boots, Sequential Compression Device